Analysts expect InflaRx N.V. (NASDAQ:IFRX) to report $-0.44 EPS on April, 4.After having $-0.31 EPS previously, InflaRx N.V.’s analysts see 41.94% EPS growth. The stock decreased 1.56% or $0.68 during the last trading session, reaching $43.01. About 73,888 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since March 26, 2018 and is uptrending. It has outperformed by 35.02% the S&P500. Some Historical IFRX News: 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 29/03/2018 – lnflaRx Full Year 2017 Financial & Operating Results; 29/03/2018 – InflaRx FY Loss/Shr EUR2.6; 08/05/2018 – INFLARX N.V. REPORTS CLOSING OF PRIMARY, SECONDARY OFFERING; 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shrs; 08/03/2018 – lnflaRx announces first patient enrolled in Phase llb trial with lead candidate IFX-1 in Hidradenitis Suppurativa
Among 2 analysts covering Hawaiian Electric Ind (NYSE:HE), 0 have Buy rating, 2 Sell and 0 Hold. Therefore 0 are positive. Hawaiian Electric Ind had 4 analyst reports since November 15, 2018 according to SRatingsIntel. Bank of America maintained Hawaiian Electric Industries, Inc. (NYSE:HE) on Tuesday, February 19 with “Sell” rating. The firm has “Underperform” rating by Bank of America given on Thursday, November 15. The stock has “Sell” rating by UBS on Tuesday, February 19. See Hawaiian Electric Industries, Inc. (NYSE:HE) latest ratings:
08/03/2019 Broker: BidaskScore Rating: Buy Upgrade
19/02/2019 Broker: Bank of America Rating: Sell New Target: $34 Maintain
19/02/2019 Broker: UBS Rating: Sell New Target: $32 Maintain
15/11/2018 Broker: Bank of America Old Rating: Neutral New Rating: Underperform Old Target: $35 New Target: $34 Downgrade
InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. The company has market cap of $1.10 billion. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The company’s lead product candidate is IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that is in the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of other chronic/autoimmune diseases.
More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Nasdaq.com which released: “Ahold Delhaize details impact of IFRS 16 accounting change, no change in underlying outlook – Nasdaq” on March 25, 2019, also Nasdaq.com with their article: “ETF Preview: ETFs, Futures Point Lower on Recession Fears; Data from Chicago and Dallas Fed Still Ahead – Nasdaq” published on March 25, 2019, Nasdaq.com published: “MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results – Nasdaq” on March 25, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Nasdaq.com and their article: “Rescuers hope to reach more cyclone victims as roads reopen in Mozambique – Nasdaq” published on March 25, 2019 as well as Nasdaq.com‘s news article titled: “Kane Biotech Announces Fourth Quarter and Full Year 2018 Financial Results – Nasdaq” with publication date: March 25, 2019.
The stock increased 0.47% or $0.19 during the last trading session, reaching $40.8. About 396,140 shares traded or 7.56% up from the average. Hawaiian Electric Industries, Inc. (NYSE:HE) has risen 17.41% since March 26, 2018 and is uptrending. It has outperformed by 13.04% the S&P500. Some Historical HE News: 10/05/2018 – HAWAIIAN ELECTRIC INDUSTRIES INC – QTRLY TOTAL REVENUE $645.9 MLN VS $591.6 MLN; 19/03/2018 – University of Hawai’i Maui College aims to be the first campus in the nation with 100-percent renewable energy generated on-sit; 08/03/2018 Hawaiian Electric launches largest renewable energy procurement effort in state history; 18/04/2018 – Hawaiian Electric and Opus One Solutions Working to Boost Distributed Energy Resources on O‘ahu Grid; 10/05/2018 – HAWAIIAN ELECTRIC 1Q REV. $645.9M, EST. $608.5M (2 EST.); 18/04/2018 – Moody’s assigns enhanced Aa3 to Custodial Receipts, Series 2018-XL0068 A & B; 19/03/2018 – University of Hawai’i Maui College aims to be the first campus in the nation with 100-percent renewable energy generated on-site with battery-enabled self-supply; 03/04/2018 – Hawaiian Electric Closes Above 200-Day Moving Average; 16/03/2018 – Hawaiian Electric Volume Jumps More Than Five Times Average; 19/04/2018 – Moody’s Fully Supported Municipal & IRB Deals
More notable recent Hawaiian Electric Industries, Inc. (NYSE:HE) news were published by: Globenewswire.com which released: “Sonoco Announces New Chief Information Officer NYSE:SON – GlobeNewswire” on March 26, 2019, also Benzinga.com with their article: “Michael Avenatti Charged With Trying To Extort Nike (NYSE:NKE) – Benzinga” published on March 25, 2019, Bizjournals.com published: “Former Regions executive joins accounting firm to grow Alabama market – Birmingham Business Journal” on March 25, 2019. More interesting news about Hawaiian Electric Industries, Inc. (NYSE:HE) were released by: Investorplace.com and their article: “Papa Johnâ€™s Stock Is a Buy in the Wake of the Shaq Deal – Investorplace.com” published on March 25, 2019 as well as Wsj.com‘s news article titled: “Levi CFO Returns to NYSE to Float Another Family-Owned American Icon – Wall Street Journal” with publication date: March 21, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.